Calidi Biotherapeutics, Inc. (CLDI)
1.17
+0.02
(+1.74%)
USD |
NYAM |
Dec 31, 16:00
1.16
-0.01
(-0.85%)
After-Hours: 20:00
Calidi Biotherapeutics EPS Diluted (Quarterly): -2.205 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.85M |
| Total Expenses (Quarterly) | 10.82M |
| Enterprise Value | 1.499M |
| Earnings Yield | -576.4% |
| Normalized Earnings Yield | -576.55 |